Otto Bock France SNC
Clinical trials sponsored by Otto Bock France SNC, explained in plain language.
A subsidiary of Ottobock, a prosthetics and orthotics manufacturer.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could a High-Tech suit help MS patients walk better? Results expected Mar 2027 (estimated)
-
Could a High-Tech suit help MS patients walk better?
Symptom relief Recruiting nowThis study tests the EXOPULSE Suit, a body garment with 50 electrodes that stimulate muscles to reduce stiffness and improve balance. 77 people with multiple sclerosis will use the suit for one hour every other day, either in active or sham mode, then switch. The goal is to see i…
Sponsor: Otto Bock France SNC • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
New prosthetic foot lets amputees change heel height like shoes
Symptom relief Recruiting nowThis study tests a special prosthetic foot that can adjust heel height from 0 to 7 cm, allowing users to wear different shoes or go barefoot. Thirty adults with leg amputations will try both their usual foot and the adjustable foot to see if it improves how they feel about their …
Sponsor: Otto Bock France SNC • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC